Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP).
Crit Care Med.
2026 Jul 1;54(7):1546-1562. doi: 10.1097/CCM.0000000000007134. Epub 2026 May 8. PubMed PMID:
42101205; PubMed Central PMCID:
PMC13322157.
Red Blood Cell Exchange Transfusion for Severe Babesiosis.
JAMA Intern Med.
2026 May 1;186(5):597-607. doi: 10.1001/jamainternmed.2026.0244. PubMed PMID:
41910966; PubMed Central PMCID:
PMC13036636.
eGFR Discordance and Its Association with Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation and Adoptive T-Cell Therapies.
J Am Soc Nephrol.
2026 Apr 21;. doi: 10.1681/ASN.0000001119. [Epub ahead of print] PubMed PMID:
42012898.
Conventional cytotoxic chemotherapy-associated nephrotoxicity: consensus report of the 34th Acute Disease Quality Initiative (ADQI) Workgroup.
Kidney Int.
2026 Jun;109(6):1114-1124. doi: 10.1016/j.kint.2026.01.037. Epub 2026 Mar 23. Review. PubMed PMID:
41881107.
Immune thrombocytopenia in patients treated with immune checkpoint inhibitors.
Blood.
2026 Mar 19;147(12):1351-1364. doi: 10.1182/blood.2025031449. PubMed PMID:
41359796.
Acute kidney injury and chronic kidney disease in the aging critically ill patient.
Intensive Care Med.
2026 May;52(5):1105-1109. doi: 10.1007/s00134-026-08385-7. Epub 2026 Mar 19. PubMed PMID:
41854915.
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup.
Nat Rev Nephrol.
2026 Apr;22(4):283-300. doi: 10.1038/s41581-025-01031-3. Epub 2025 Dec 8. Review. PubMed PMID:
41361704.
Randomized trial of activated vitamin D for acute kidney injury prevention in critically ill patients.
JCI Insight.
2025 Oct 22;10(20). doi: 10.1172/jci.insight.193523. eCollection 2025 Oct 22. PubMed PMID:
40924491; PubMed Central PMCID:
PMC12581674.
Higher Urinary Iron Levels Are Associated with Kidney Dysfunction, Tubular Damage, and Increased Mortality in Kidney Transplant Recipients.
Kidney360.
2025 Nov 1;6(11):1970-1980. doi: 10.34067/KID.0000000878. Epub 2025 Jun 26. PubMed PMID:
40569672; PubMed Central PMCID:
PMC12626665.
Oral MIB-626 (β Nicotinamide Mononucleotide) Safely Raises Blood Nicotinamide Adenine Dinucleotide Levels in Hospitalized Patients With COVID-19 and Acute Kidney Injury: A Randomized Controlled Trial.
FASEB Bioadv.
2025 Aug;7(8):e70011. doi: 10.1096/fba.2025-00014. eCollection 2025 Aug. PubMed PMID:
40746868; PubMed Central PMCID:
PMC12312518.
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury.
JAMA Oncol.
2025 Jun 1;11(6):636-643. doi: 10.1001/jamaoncol.2025.0756. PubMed PMID:
40272825; PubMed Central PMCID:
PMC12022858.
Glucarpidase for treatment of high-dose methotrexate toxicity.
Blood.
2025 Apr 24;145(17):1858-1869. doi: 10.1182/blood.2024026211. PubMed PMID:
39760780; PubMed Central PMCID:
PMC12782973.
Another Win for SGLT2 Inhibitors in Chronic Kidney Disease.
N Engl J Med.
2025 Feb 20;392(8):822-823. doi: 10.1056/NEJMe2500233. PubMed PMID:
39970403; PubMed Central PMCID:
PMC13147510.
Cardiac Surgery-Associated Acute Kidney Injury: An Updated Review of Current Preventive Strategies.
Anesthesiol Clin.
2025 Jun;43(2):323-356. doi: 10.1016/j.anclin.2025.01.001. Epub 2025 Feb 15. Review. PubMed PMID:
40348546.
Effect of mannitol on cisplatin-associated acute kidney injury: a target trial emulation.
Nephrol Dial Transplant.
2025 Feb 4;40(2):405-408. doi: 10.1093/ndt/gfae233. PubMed PMID:
39415423; PubMed Central PMCID:
PMC11792662.
Improving Processes of Care after Acute Kidney Injury.
J Am Soc Nephrol.
2025 Mar 1;36(3):339-341. doi: 10.1681/ASN.0000000548. Epub 2024 Oct 24. PubMed PMID:
39446577; PubMed Central PMCID:
PMC11888948.
Diagnosis and management of immune checkpoint inhibitor-associated nephrotoxicity: a position statement from the American Society of Onco-nephrology.
Kidney Int.
2025 Jan;107(1):21-32. doi: 10.1016/j.kint.2024.09.017. Epub 2024 Oct 24. PubMed PMID:
39455026.
F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injury.
J Clin Invest.
2024 Aug 8;134(18). doi: 10.1172/JCI182275. PubMed PMID:
39115940; PubMed Central PMCID:
PMC11405038.
Afamelanotide for Treatment of the Protoporphyrias: Impact on Quality of Life and Laboratory Parameters in a US Cohort.
Life (Basel).
2024 May 28;14(6). doi: 10.3390/life14060689. PubMed PMID:
38929673; PubMed Central PMCID:
PMC11204624.
Sarcopenia, adiposity and large discordance between cystatin C and creatinine-based estimated glomerular filtration rate in patients with cancer.
J Cachexia Sarcopenia Muscle.
2024 Jun;15(3):1187-1198. doi: 10.1002/jcsm.13469. Epub 2024 Apr 22. PubMed PMID:
38646842; PubMed Central PMCID:
PMC11154767.
We need more data to help guide the care of patients with cancer who develop kidney related problems.
BMJ.
2024 Mar 27;384:q751. doi: 10.1136/bmj.q751. PubMed PMID:
38538030.
Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study.
BMJ.
2024 Mar 27;384:e077169. doi: 10.1136/bmj-2023-077169. PubMed PMID:
38538012; PubMed Central PMCID:
PMC10964715.
Iron as an emerging therapeutic target in critically ill patients.
Crit Care.
2023 Dec 4;27(1):475. doi: 10.1186/s13054-023-04759-1. Review. PubMed PMID:
38049866; PubMed Central PMCID:
PMC10694984.
Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
JAMA.
2023 Nov 14;330(18):1745-1759. doi: 10.1001/jama.2023.21407. PubMed PMID:
37877585; PubMed Central PMCID:
PMC10600726.
AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipients.
Bone Marrow Transplant.
2024 Feb;59(2):178-188. doi: 10.1038/s41409-023-02136-8. Epub 2023 Nov 7. PubMed PMID:
37935783.
Platelet Factor 4 Antibodies and Severe AKI.
Kidney360.
2023 Dec 1;4(12):1672-1679. doi: 10.34067/KID.0000000000000287. Epub 2023 Nov 1. PubMed PMID:
37907435; PubMed Central PMCID:
PMC10758522.
Simvastatin in Critically Ill Patients with Covid-19.
N Engl J Med.
2023 Dec 21;389(25):2341-2354. doi: 10.1056/NEJMoa2309995. Epub 2023 Oct 25. PubMed PMID:
37888913; PubMed Central PMCID:
PMC10755839.
High-dose IV magnesium in mesothelioma patients receiving surgery with hyperthermic intraoperative cisplatin: Pilot studies and design of a phase II randomized clinical trial.
J Surg Oncol.
2023 Dec;128(7):1141-1149. doi: 10.1002/jso.27412. Epub 2023 Sep 13. PubMed PMID:
37702402; PubMed Central PMCID:
PMC10592264.
Adverse Effects of Tocilizumab Versus Baricitinib in Severe COVID-19.
Crit Care Med.
2023 Sep 1;51(9):e184-e185. doi: 10.1097/CCM.0000000000005933. Epub 2023 Aug 17. PubMed PMID:
37589523.
Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial.
Res Pract Thromb Haemost.
2023 Aug;7(6):102167. doi: 10.1016/j.rpth.2023.102167. eCollection 2023 Aug. PubMed PMID:
37727846; PubMed Central PMCID:
PMC10506136.
Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With Cancer.
JAMA Netw Open.
2023 Jul 3;6(7):e2321715. doi: 10.1001/jamanetworkopen.2023.21715. PubMed PMID:
37405775; PubMed Central PMCID:
PMC10323710.
Timing of invasive mechanical ventilation and death in critically ill adults with COVID-19: A multicenter cohort study.
PLoS One.
2023;18(6):e0285748. doi: 10.1371/journal.pone.0285748. eCollection 2023. PubMed PMID:
37379286; PubMed Central PMCID:
PMC10306211.
Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study.
Oncologist.
2023 Jun 2;28(6):e379-e390. doi: 10.1093/oncolo/oyad001. PubMed PMID:
36821637; PubMed Central PMCID:
PMC10243781.
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
JAMA.
2023 Apr 11;329(14):1183-1196. doi: 10.1001/jama.2023.4480. PubMed PMID:
37039790; PubMed Central PMCID:
PMC10326520.
Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.
Transplant Cell Ther.
2023 Jul;29(7):455.e1-455.e9. doi: 10.1016/j.jtct.2023.03.029. Epub 2023 Apr 2. PubMed PMID:
37015320; PubMed Central PMCID:
PMC10330095.
Author Correction: Therapeutic advances in COVID-19.
Nat Rev Nephrol.
2023 Apr;19(4):273. doi: 10.1038/s41581-023-00686-0. PubMed PMID:
36747084; PubMed Central PMCID:
PMC9901371.
Reply to 'Use of convalescent plasma in the treatment of COVID-19'.
Nat Rev Nephrol.
2023 Apr;19(4):272. doi: 10.1038/s41581-023-00691-3. PubMed PMID:
36806371; PubMed Central PMCID:
PMC9937737.
Safety of Nirmatrelvir/Ritonavir in Dialysis Patients with COVID-19: The End of the Beginning?.
Clin J Am Soc Nephrol.
2023 Apr 1;18(4):427-429. doi: 10.2215/CJN.0000000000000129. PubMed PMID:
37026748; PubMed Central PMCID:
PMC10103203.
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
JAMA.
2023 Jan 3;329(1):39-51. doi: 10.1001/jama.2022.23257. PubMed PMID:
36525245; PubMed Central PMCID:
PMC9857594.
Target Trial Emulation: A Framework for Causal Inference From Observational Data.
JAMA.
2022 Dec 27;328(24):2446-2447. doi: 10.1001/jama.2022.21383. PubMed PMID:
36508210.
Therapeutic advances in COVID-19.
Nat Rev Nephrol.
2023 Jan;19(1):38-52. doi: 10.1038/s41581-022-00642-4. Epub 2022 Oct 17. Review. PubMed PMID:
36253508; PubMed Central PMCID:
PMC9574806.
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19.
Circ Cardiovasc Qual Outcomes.
2022 Oct;15(10):e008942. doi: 10.1161/CIRCOUTCOMES.122.008942. Epub 2022 Oct 4. PubMed PMID:
36193749; PubMed Central PMCID:
PMC9575399.
Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury.
Nat Rev Nephrol.
2022 Dec;18(12):794-805. doi: 10.1038/s41581-022-00630-8. Epub 2022 Sep 27. Review. PubMed PMID:
36168055.
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI.
J Immunother Cancer.
2022 Sep;10(9). doi: 10.1136/jitc-2022-005646. PubMed PMID:
36137651; PubMed Central PMCID:
PMC9511654.
Modulation of the Association Between Age and Death by Risk Factor Burden in Critically Ill Patients With COVID-19.
Crit Care Explor.
2022 Sep;4(9):e0755. doi: 10.1097/CCE.0000000000000755. eCollection 2022 Sep. PubMed PMID:
36050992; PubMed Central PMCID:
PMC9426819.
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.
Kidney Int.
2022 Oct;102(4):930-935. doi: 10.1016/j.kint.2022.07.019. Epub 2022 Aug 11. PubMed PMID:
35964800; PubMed Central PMCID:
PMC9523226.
Hispanic ethnicity and mortality among critically ill patients with COVID-19.
PLoS One.
2022;17(5):e0268022. doi: 10.1371/journal.pone.0268022. eCollection 2022. PubMed PMID:
35584148; PubMed Central PMCID:
PMC9116663.
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
JAMA.
2022 Apr 5;327(13):1247-1259. doi: 10.1001/jama.2022.2910. PubMed PMID:
35315874; PubMed Central PMCID:
PMC8941448.
Association of Surge Conditions with Mortality Among Critically Ill Patients with COVID-19.
J Intensive Care Med.
2022 Apr;37(4):500-509. doi: 10.1177/08850666211067509. Epub 2021 Dec 23. PubMed PMID:
34939474; PubMed Central PMCID:
PMC8926920.
Sex-related differences in mortality, acute kidney injury, and respiratory failure among critically ill patients with COVID-19.
Medicine (Baltimore).
2021 Dec 17;100(50):e28302. doi: 10.1097/MD.0000000000028302. PubMed PMID:
34918709; PubMed Central PMCID:
PMC8677989.
What would you like to do?